95 results on '"Caniglia S"'
Search Results
2. Vulnerability to Parkinson's Disease: Towards an Unifying Theory of Disease Etiology
3. Neuroendocrine–immune (NEI) circuitry from neuron–glial interactions to function: Focus on gender and HPA–HPG interactions on early programming of the NEI system
4. The reproductive system at the neuroendocrine-immune interface: focus on LHRH, estrogens and growth factors in LHRH neuron–glial interactions
5. Estrogen, neuroinflammation and neuroprotection in Parkinson’s disease: Glia dictates resistance versus vulnerability to neurodegeneration
6. GSK-3β-induced Tau pathology drives hippocampal neuronal cell death in Huntington’s disease: involvement of astrocyte–neuron interactions
7. GENDER DIFFERENCE IN THE RESPONSE OF ADULT SUBVENTRICULARZONE (SVZ) NEUROPROGENITORS IN A MOUSE MODEL OF PARKINSON’DISEASE: CRITICAL ROLE OF ESTROGEN
8. MPTP-reactive 'in situ' inflammation as a key event in the molecular cascade linking nigrostriatal injury to repair
9. Il dolore nella chirurgia dell'ernia inguinale
10. Steroid hormone modulation of glial inducible nitric oxide synthase orchestrate neuroprotection in experimental parkinsonisin
11. Steroid hormone modulation of glial inducible bitric oxide synthase orchestrate neuroprotection in experimental parkinsonism
12. Glucorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide
13. Estrogen triggers astrocyte-microglia crosstalk in experimental Parkinsonism: Implications for neuroprotection
14. IMAGING NITROSATIVE STRESS IN PIMARY ASTROGLIAL CULTURES: PROTECTION OF ASTROGLIA FROM NITROSATIVE/OXIDATIVE STRESS-INDUCED CELL DEATH BY RED ORANGE EXTRACT
15. Early embryonic life exposure to dysfunctional glucocorticoid receptor(GR) programs astroglial response to inflammation via GR-nitric oxide crosstalk: Long term implications for autoimmune disorders of the CNS
16. Neuroinfiammazione, NOS inducibile e glucocorticoidi nella programmazione della vulnerabilità al danno neurodegenerativo
17. Exposure to a dysfunctional GR from early embryonic life programs the resistance to experimental autoimmune encephalomyelitis via NO-induced immunosuppression. J. Immunology
18. Aging-Induced Nrf2-ARE Pathway Disruption in the Subventricular Zone Drives Neurogenic Impairment in Parkinsonian Mice via PI3K-Wnt/ -Catenin Dysregulation
19. Plasticity of Subventricular Zone Neuroprogenitors in MPTP (1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine) Mouse Model of Parkinson's Disease Involves Cross Talk between Inflammatory and Wnt/ -Catenin Signaling Pathways: Functional Consequences for Neuroprotection and Repair
20. Corrigendum to “Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease” [Neurobiol. Dis. 41/2 (2011) 508–527]
21. Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
22. P3.048 MPTP-reactive “in situ” inflammation as a key event in the molecular cascade linking nigrostriatal injury to repair
23. Loss of aromatase cytochrome P450 function as a risk factor for Parkinson's disease?
24. Pulmonary lesions of disseminated lupus erythematosus.
25. Stress, the immune system and vulnerability to degenerative disorders of the central nervous system in transgenic mice expressing glucocorticoid receptor antisense RNA
26. CARDILLO A , SCRIMALI T, CARUSO F, CANIGLIA S , MACAUDA C , RAPISARDA V ORGANIZZAZIONE E CONDUZIONE DI UN LABORATORIO PER IL MONITORAGGIO SISTEMATICO DELLA RESISTENZA CUTANEA
27. ANALISI E CONTROLLO SIMULTANEI DEL LIVELLO EMOTIVO, VIA GSR (GALVANIC SKIN RESPONSE), PER UN TRAINING 'PILOTATO' RILASSAMENTO
28. LDOC1 expression in fibroblasts of patients with Down syndrome
29. A rare complication of the hepatic hydatid cyst: Intraperitoneal perforation without anaphylaxis
30. Astrocytes from distinct nigrostriatal brain regions secrete extracellular vesicles able to mediate neuroprotection in cellular models of Parkinson's disease
31. Early embryonic life exposure to dysfunctional glucocorticoid receptor (GR) programs astroglial response to inflammation via GR-nitric oxide crosstalk: Long-term implications for autoimmune disorders of the CNS
32. Ultrastructural and molecular characterization of astrocyte-derived extracellular vesicles from nigrostriatal brain regions: implications for dopaminergic neuroprotection
33. Exposure to a dysfunctional glucocorticoid receptor from early embryonic life programs the resistance to experimental autoimmune encephalomyelitis via nitric oxide-induced immunosuppression
34. Glia as a turning point in the therapeutic strategy of Parkinson's disease
35. Gender, neuroendocrine-immune interactions and neuron-glial plasticity: Role of luteinizing hormone-releasing hormone (LHRH)
36. A Wnt1 regulated Frizzled-1/β-Catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: Therapeutical relevance for neuron survival and neuroprotection
37. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
38. Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease
39. Bilirubin protects astrocytes from its own toxicity by inducing up-regulation and translocation of multidrug resistance-associated protein 1 (Mrp1)
40. Transcriptome Study in Sicilian Patients with Autism Spectrum Disorder.
41. A Next-Generation Sequencing Study in a Cohort of Sicilian Patients with Parkinson's Disease.
42. Humanin gene expression in subjects with Parkinson's disease.
43. Small Extracellular Vesicles Secreted by Nigrostriatal Astrocytes Rescue Cell Death and Preserve Mitochondrial Function in Parkinson's Disease.
44. CCR3 gene overexpression in patients with Down syndrome.
45. Extracellular Vesicles as Nanotherapeutics for Parkinson's Disease.
46. Glia-Derived Extracellular Vesicles in Parkinson's Disease.
47. Boosting Antioxidant Self-defenses by Grafting Astrocytes Rejuvenates the Aged Microenvironment and Mitigates Nigrostriatal Toxicity in Parkinsonian Brain via an Nrf2-Driven Wnt/β-Catenin Prosurvival Axis.
48. Parkinson's disease, aging and adult neurogenesis: Wnt/β-catenin signalling as the key to unlock the mystery of endogenous brain repair.
49. Humanin gene expression in fibroblast of Down syndrome subjects.
50. Neural Stem Cell Grafts Promote Astroglia-Driven Neurorestoration in the Aged Parkinsonian Brain via Wnt/β-Catenin Signaling.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.